MARKET

AUPH

AUPH

Aurinia Pharmace
NASDAQ
15.48
+0.03
+0.16%
Opening 13:30 08/11 EDT
OPEN
15.50
PREV CLOSE
15.45
HIGH
15.59
LOW
15.31
VOLUME
315.50K
TURNOVER
--
52 WEEK HIGH
19.25
52 WEEK LOW
10.34
MARKET CAP
2.06B
P/E (TTM)
6.76
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Tactile Systems Technology (TCMD)
TipRanks · 4h ago
Weekly Report: what happened at AUPH last week (0803-0807)?
Weekly Report · 1d ago
Aurinia Pharmaceuticals Is Maintained at Sector Perform by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Sector Perform on Aurinia Pharmaceuticals, Raises Price Target to $16
Benzinga · 3d ago
Aurinia Pharmaceuticals price target raised to $16 from $15 at RBC Capital
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: VistaGen Therapeutics (VTGN), Iovance Biotherapeutics (IOVA) and Aurinia Pharmaceuticals (AUPH)
TipRanks · 5d ago
Aurinia Posts Strong Q2 Results, Reaffirms 2026 Outlook and Advances Autoimmune Pipeline
TipRanks · 5d ago
Aurinia Pharmaceuticals Affirms FY2026 Sales Guidance of $315.000M-$325.000M vs $323.065M Est
Benzinga · 5d ago
More
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support the LUPKYNIS development program. The Company is also developing aritinercept (AUR200), a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. It sells LUPKYNIS to specialty pharmacies and a specialty distributor in the United States and sells LUPKYNIS inventory to its collaboration partner, Otsuka Pharmaceutical Co., Ltd. (Otsuka), for the European and Japanese market. The Company sells encapsulated voclosporin to its collaboration partner, Otsuka, which Otsuka then sells to customers in its territories.

Webull offers Aurinia Pharmaceuticals Inc stock information, including NASDAQ: AUPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AUPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AUPH stock methods without spending real money on the virtual paper trading platform.